PSY-8152 v1

Gómez-Coronado, N., Sethi, R., Bortolasci, C. C., Arancini, L., Berk, M., & Dodd, S. (2018, December). A review of the neurobiological underpinning of comorbid substance use and mood disorders. Journal of Affective Disorders, 241, 388–401.
This article provides valuable information on the neurological activities involved in the use of substances and the development of mood disorders. Pay attention to the discussion section as there is a strong summary of the gathered information.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders, fifth edition. Author.
This resource will be used to evaluate symptoms of depressive disorders.

Vilsaint, C. L., NeMoyer, A., Fillbrunn, M., Sadikova, E., Kessler, R. C., Sampson, N. A., Alvarez, K., Green, J. G., McLaughlin, K. A., Chen, R., Williams, D. R., Jackson, J. S., & Alegría, M. (2019, February). Racial/ethnic differences in 12-month prevalence and persistence of mood, anxiety, and substance use disorders: Variation by nativity and socioeconomic status. Comprehensive Psychiatry, 89, 52–60.
The article provides relevant data on the racial differences in the development of co-occurring disorders. The results section has a great deal of interesting data, and the discussion section pulls this data together in a straightforward manner.

Wolitzky-Taylor, K., Krull, J., Rawson, R., Roy-Byrne, P., Ries, R., & Craske, M. G. (2018). Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics. Journal of Consulting and Clinical Psychology, 86(1), 81–88.
This resource is important as the treatment design compares a specialized intervention with treatment as usual. Pay specific attention to the discussion on the fidelity of the application of the intervention.

Turner, S., Mota, N., Bolton, J., & Sareen, J. (2018). Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depression and Anxiety, 35(9), 851–860.
This article provides insights into the epidemiology (incidences) of self-medicating behaviors for anxiety disorders and other mood disorders. Pay particular attention to the results section and clinical implications sections as there are great insights into the onset of substance use with various mood conditions.

Brenner, P., Brandt, L., Li, G., DiBernardo, A., Bodén, R., & Reutfors, J. (2019). Treatment‐resistant depression as risk factor for substance use disorders—A nation‐wide register‐based cohort study. Addiction, 114(7), 1274–1282.
This is an important resource because the issue of treatment-resistant depression is examined. Pay attention to the explanation of treatment-resistant depression and which populations have the greatest risk for this condition.